Basal cell carcinoma (BCC) stands as one of the most prevalent malignant epithelial skin tumors worldwide, and it is characterized by diverse clinical forms with locally destructive growth and a high recurrence rate. Usually, this type of cancer is more common in individuals over the age of 60. Therefore, the current study discusses contemporary approaches to treating basal cell carcinoma, highlighting the advantages and disadvantages of potential therapeutic options.